Lensar Share Price (NASDAQ: LNSR)

$12.27

▲

0.12

(0.99%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Lensar Stock chart to analyse performance

Lensar stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$12.10
Today's High:$12.28
$12.27
1.43%
Downside
Day's Volatility :1.51%
Upside
0.08%
52 Weeks Low:$3.80
52 Weeks High:$17.31
$12.27
69.03%
Downside
52 Weeks Volatility :78.05%
Upside
29.12%

Lensar Stock Returns

Period	Lensar Inc	Index (Russel 2000)
3 Months	-9.17%	0.0%
6 Months	-8.9%	0.0%
1 Year	165.23%	0.0%
3 Years	117.73%	-4.1%

Lensar Inc Key Stats

Check Lensar key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$12.15
Open	$12.095
Today's High	$12.28
Today's Low	$12.095
Market Capitalization	$145.0M
Today's Volume	$71.8K
52 Week High	$17.31
52 Week Low	$3.8001
Revenue TTM	$58.4M
EBITDA	$-3.3M
Earnings Per Share (EPS)	$-4.21
Profit Margin	-84.49%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-350.22%

Stock Returns calculator for Lensar Stock including INR - Dollar returns

The Lensar stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lensar investment value today

Current value as on today

₹2,70,295

Returns

₹1,70,295

(+170.29%)

Returns from Lensar Stock

₹1,65,011 (+165.01%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lensar Stock

-36%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lensar Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lensar Inc

Name
Holdings %
Name
Holdings %
Brandes Investment Partners & Co
4.72%
Vanguard Group Inc
4.24%
Renaissance Technologies Corp
2.63%
Tudor Investment Corp Et AL
2.32%
Dimensional Fund Advisors, Inc.
1.88%
Css LLC
1.53%

Analyst Recommendation on Lensar Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Lensar(by analysts ranked 0 to 5 stars)

Lensar Share Price Target

What analysts predicted

Upside of 22.25%

Target:

$15.00

Current:

$12.27

Lensar share price target is $15.00, a slight Upside of 22.25% compared to current price of $12.27 as per analysts' prediction.

Lensar Stock Insights

Price Movement
In the last 1 year, LNSR stock has moved up by 163.0%
Decreasing Revenue
Revenue is down for the last 3 quarters, 16.73M → 13.93M (in $), with an average decrease of 8.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -27.34M → -1.76M (in $), with an average increase of 1450.2% per quarter
LNSR vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 161.7% return, outperforming this stock by 33.9%

Lensar Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$30.5M	↑ 25.18%
Net Income	$-14.7M	↑ 16.39%
Net Profit Margin	-48.01%	↑ 3.63%

	FY20	Y/Y Change
Revenue	$26.4M	↓ 13.58%
Net Income	$-19.8M	↑ 34.91%
Net Profit Margin	-74.95%	↓ 26.94%

	FY21	Y/Y Change
Revenue	$34.5M	↑ 30.62%
Net Income	$-19.7M	↓ 0.62%
Net Profit Margin	-57.03%	↑ 17.92%

	FY22	Y/Y Change
Revenue	$35.4M	↑ 2.61%
Net Income	$-19.9M	↑ 1.33%
Net Profit Margin	-56.32%	↑ 0.71%

	FY23	Y/Y Change
Revenue	$42.2M	↑ 19.25%
Net Income	$-14.4M	↓ 27.77%
Net Profit Margin	-34.11%	↑ 22.21%

	FY24	Y/Y Change
Revenue	$53.5M	↑ 26.87%
Net Income	$-31.4M	↑ 118.34%
Net Profit Margin	-58.71%	↓ 24.6%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$10.6M	↓ 12.53%
Net Income	$-2.2M	↓ 45.06%
Net Profit Margin	-20.37%	↑ 12.06%

	Q2 FY24	Q/Q Change
Revenue	$12.6M	↑ 19.34%
Net Income	$-9.0M	↑ 319.24%
Net Profit Margin	-71.57%	↓ 51.2%

	Q3 FY24	Q/Q Change
Revenue	$13.5M	↑ 7.15%
Net Income	$-1.5M	↓ 83.39%
Net Profit Margin	-11.09%	↑ 60.48%

	Q4 FY24	Q/Q Change
Revenue	$16.7M	↑ 23.58%
Net Income	$-18.7M	↑ 1145.14%
Net Profit Margin	-111.78%	↓ 100.69%

	Q1 FY25	Q/Q Change
Revenue	$14.2M	↓ 15.37%
Net Income	$-27.3M	↑ 46.21%
Net Profit Margin	-193.13%	↓ 81.35%

	Q2 FY25	Q/Q Change
Revenue	$13.9M	↓ 1.58%
Net Income	$-1.8M	↓ 93.55%
Net Profit Margin	-12.66%	↑ 180.47%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$13.2M	↑ 37.64%

	FY20	Y/Y Change
Profit	$14.1M	↑ 6.4%

	FY21	Y/Y Change
Profit	$17.8M	↑ 26.7%

	FY22	Y/Y Change
Profit	$20.0M	↑ 11.9%

	FY23	Y/Y Change
Profit	$21.1M	↑ 5.77%

	FY24	Y/Y Change
Profit	$25.9M	↑ 22.48%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$5.4M	↑ 10.54%

	Q2 FY24	Q/Q Change
Profit	$6.6M	↑ 22.1%

	Q3 FY24	Q/Q Change
Profit	$6.3M	↓ 4.79%

	Q4 FY24	Q/Q Change
Profit	$7.1M	↑ 13.44%

	Q1 FY25	Q/Q Change
Profit	$7.1M	↑ 0.24%

	Q2 FY25	Q/Q Change
Profit	$7.0M	↓ 1.42%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-12.6M	↑ 567.85%
Investing Cash Flow	$-2.1M	↓ 46.33%
Financing Cash Flow	$15.9M	↑ 129.32%

	FY20	Y/Y Change
Operating Cash Flow	$-13.8M	↑ 9.55%
Investing Cash Flow	$-326.0K	↓ 84.39%
Financing Cash Flow	$50.0M	↑ 213.51%

	FY21	Y/Y Change
Operating Cash Flow	$-9.0M	↓ 34.96%
Investing Cash Flow	$-354.0K	↑ 8.59%
Financing Cash Flow	$361.0K	↓ 99.28%

	FY22	Y/Y Change
Operating Cash Flow	$-14.9M	↑ 65.64%
Investing Cash Flow	$-115.0K	↓ 67.51%
Financing Cash Flow	$-2.0M	↓ 651.8%

	FY23	Y/Y Change
Operating Cash Flow	$-9.7M	↓ 34.98%
Investing Cash Flow	$-4.2M	↑ 3513.91%
Financing Cash Flow	$19.8M	↓ 1092.07%

	FY24	Y/Y Change
Operating Cash Flow	$-2.3M	↓ 76.45%
Investing Cash Flow	$-2.2M	↓ 48.0%
Financing Cash Flow	$78.0K	↓ 99.61%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-5.3M	↑ 1005.63%
Investing Cash Flow	$-1.2M	↓ 69.08%
Financing Cash Flow	$-130.0K	↓ 189.04%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-3.8M	↓ 28.81%
Investing Cash Flow	$-2.0M	↑ 64.93%
Financing Cash Flow	$129.0K	↓ 199.23%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$3.2M	↓ 183.46%
Investing Cash Flow	$-905.0K	↓ 55.24%
Financing Cash Flow	$-93.0K	↓ 172.09%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$3.7M	↑ 15.98%
Investing Cash Flow	$2.0M	↓ 320.11%
Financing Cash Flow	$172.0K	↓ 284.95%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-6.9M	↓ 289.72%
Investing Cash Flow	$531.0K	↓ 73.34%
Financing Cash Flow	$9.7M	↑ 5534.3%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-5.0M	↓ 27.96%
Investing Cash Flow	$-7.5M	↓ 1510.92%
Financing Cash Flow	$93.0K	↓ 99.04%

Lensar Technicals Summary

Sell

Neutral

Buy

Lensar is currently in a neutral trading position according to technical analysis indicators.

Lensar Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lensar Inc	-2.62%	-8.9%	165.23%	117.73%	36.44%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Abbott Laboratories	4.24%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lensar Inc	NA	NA	NA	-0.39	-3.5	-0.07	NA	-1.93
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lensar Inc	Buy	$145.0M	36.44%	NA	-84.49%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Lensar Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Organization	Lensar
Employees	140
CEO	Mr. Nicholas T. Curtis
Industry	Health Technology

Key Management of Lensar Inc

Name	Title
Mr. Nicholas T. Curtis	President, CEO & Director
Mr. Thomas R. Staab II, CPA	CFO & Secretary
Mr. Alan B. Connaughton	Chief Operating Officer
Ms. Kendra W. Wong	Principal Accounting Officer

Important FAQs about investing in LNSR Stock from India :

What is Lensar share price today?

Lensar share price today is $12.27 as on August 30, 2025 at 1:29 am IST at the close of the market. Lensar share today touched a day high of $12.28 and a low of $12.10.

What is the 52 week high and 52 week low for Lensar share?

Lensar share touched a 52 week high of $17.31 and a 52 week low of $3.80. Lensar stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $12.27, lower by 29.12% versus the 52 week high.

How to invest in Lensar Stock (LNSR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lensar on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lensar Shares that will get you 0.1222 shares as per Lensar share price of $12.27 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lensar Stock (LNSR) from India?

Indian investors can start investing in Lensar (LNSR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lensar stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lensar share’s latest price of $12.27 as on August 30, 2025 at 1:29 am IST, you will get 0.8150 shares of Lensar. Learn more about fractional shares .

What are the returns that Lensar has given to Indian investors in the last 5 years?

Lensar stock has given 36.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?